Cinclus Pharma Holding AB (publ) (STO:CINPHA)
12.42
+0.22 (1.80%)
At close: Sep 3, 2026
Cinclus Pharma Holding AB Revenue
Cinclus Pharma Holding AB had revenue of 1.77M SEK in the quarter ending June 30, 2026, a decrease of -94.82%. This brings the company's revenue in the last twelve months to 35.18M, down -9.04% year-over-year. In the year 2025, Cinclus Pharma Holding AB had annual revenue of 57.47M with 1,154.80% growth.
Revenue (ttm)
35.18M
Revenue Growth
-9.04%
P/S Ratio
16.70
Revenue / Employee
2.07M
Employees
17
Market Cap
587.31M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 57.47M | 52.89M | 1,154.80% |
| Dec 31, 2024 | 4.58M | -1.38M | -23.14% |
| Dec 31, 2023 | 5.96M | -4.61M | -43.63% |
| Dec 31, 2022 | 10.57M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| EQL Pharma AB | 432.35M |
| Enzymatica AB | 51.93M |
| Newbury Pharmaceuticals AB | 35.02M |
| Nanexa AB | 33.86M |
| Moberg Pharma AB | 16.76M |
| Orexo AB | 16.60M |
| Enorama Pharma AB | 3.26M |
| Dicot Pharma AB | 200.00K |
Cinclus Pharma Holding AB News
- 16 days ago - Cinclus Pharma Holding AB Earnings Call Transcript: Q2 2026 - Transcripts
- 16 days ago - Cinclus Pharma Holding AB Quarterly report: Q2 2026 - Filings
- 16 days ago - Cinclus Pharma Holding AB Slides: Q2 2026 - Filings
- 3 months ago - Cinclus Pharma Holding AB Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 3 months ago - Cinclus Pharma Holding AB Earnings Call Transcript: Q1 2026 - Transcripts
- 3 months ago - Cinclus Pharma Holding AB Quarterly report: Q1 2026 - Filings
- 3 months ago - Cinclus Pharma Holding AB Slides: Q1 2026 - Filings
- 6 months ago - Cinclus Pharma Holding AB Earnings Call Transcript: Q4 2025 - Transcripts